santa cruz biotechnology, inc.

| |
|
| | Sphingolipid Biosynthesis and Metabolism
- 3-O-Methylsphingomyelin
A novel selective inhibitor of neutral sphingomyelinase, (Ki=37 µM) that is cell-permeable and does not inhibit acid sphingomyelinase1. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205580 | n.n. | C32H65N2O6P | 1 mg/5 mg |
- Ceramide phosphorylethanolamine
Sphingolipid with ethanolamine base, found in insect membranes.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-300332 | n.n. | C38H77N2O6P | 5 mg |
- D-erythro-Ceramide C8 1-phosphate
Cell permeable stimulator of DNA synthesis in cultured fibroblasts; antagonizes mitogenic activity.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-300407 | n.n. | C26H52NO6P | 1 mg |
- D-erythro-Ceramine C8
Inert to ceramidases; induces peak DNA fragmentation in 6 hrs; induces apoptosis in U937 cells.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-300408 | n.n. | C26H53NO2 | 1 mg |
- D-erythro-Dihydrosphingosine 1-phosphate
Negative control for sphingosine-1-phosphate.
| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-300409 | n.n. | C18H40NO5P | 1 mg |
- DL-PDMP
PDMP is a ceramide analog first prepared in a search for inhibitors of glucosylceramide synthase.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201391 | 73257-80-4 | C23H38N2O3 ·HCl | 10 mg/50 mg |
- DL-PPMP
This compound inhibits glucosylceramide synthetase and is more effective than PDMP in intact cells.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205655 | 149022-18-4 | C29H50N2O3 ·HCl | 5 mg/25 mg |
- DL-threo-Dihydrosphingosine
An inhibitor of sphingosine kinase activity, suppressing the generation of sphingosine-1-phosphate. Used as a tool to identify sphingosine kinase activity in various processes.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201389 | 73938-69-9 | C18H39NO2 | 10 mg/50 mg |
- Fumonisin B1
A fungal metabolite that inhibits serine/threonine phosphatases. Ceramide inhibition and induces apoptosis. Also increases immunotoxic effects by increasing expression of IL-1β, TNFα, IFN-©, IL-1α, IL-6, IL-10, IL-18 and IL- and CXCL9.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201395 | 116355-83-0 | C34H59NO15 | 1 mg/5 mg |
- Fumonisin B2
A structural analog of fumonisin B1 noted to inhibit sphingosine acyltransferase.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201393 | 116355-84-1 | C34H59NO14 | 1 mg/5 mg |
- L-Cycloserine
An irreversible inhibitor of 3-ketodihydrosphingosine synthetase, which is the first enzyme of the sphingolipid pathway, and causes the synthesis of sphingolipids to decrease.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201387 | 339-72-0 | C3H6N2O2 | 100 mg/500 mg |
- L-erythro MAPP
Useful as a negative control for D-erythro-MAPP where it does not raise endogenous ceramide levels or inhibit the growth of HL-60 cells1. | Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-205740 | 143492-38-0 | C23H39NO2 | 5 mg/25 µg |
- Myriocin (ISP-1)
A small molecule inhibitor of serine palmitoyltransferase, necessary for sphingolipid biosynthesis. A tool for depleting cells of sphingolipids.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201397 | 35891-70-4 | C21H39NO6 | 5 mg |
- N-Butyldeoxynojirimycin·HCl
Inhibits glucosylceramide synthase as well as α-glucosidase I and II without ceramide accumulation or cell death.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201398 | 72599-27-0 | C10H21NO4··HCl | 5 mg/25 mg |
- Oleylethanolamide
A naturally occurring lipid analogue of the endogenous cannabinoid anandamide (sc-200790). Has been noted to cause activation of Neu/ErbB2 receptors.| Katalog # | CAS Nummer | Summenformel | Menge |
|---|
| sc-201400 | 111-58-0 | C20H39NO2 | 10 mg/50 mg |
|